Muriel Buri
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Managing transient immune complex reactions in patients with paroxysmal nocturnal hemoglobinuria: clinical observations from the COMMODORE 1 and 2 studies.
Journal: Therapeutic advances in hematology
Published: February 11, 2025
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies.
Journal: European journal of haematology
Published: August 14, 2024
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial.
Journal: European journal of haematology
Published: January 16, 2023
Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
Journal: British journal of haematology
Published: May 19, 2021
Unbiased Recursive Partitioning Enables Robust and Reliable Outcome Prediction in Acute Spinal Cord Injury.
Journal: Journal of neurotrauma
Published: February 23, 2021
Correction to: Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes.
Journal: BMC medical research methodology
Published: July 10, 2020
Model-based random forests for ordinal regression.
Journal: The international journal of biostatistics
Published: May 31, 2019
Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes.
Journal: BMC medical research methodology
Published: March 20, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026